Redhawk Wealth Advisors, Inc. Charles River Laboratories International, Inc. Transaction History

Redhawk Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$255.51 - $362.11 $762,952 - $1.08 Million	-2,986 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$351.38 - $448.68 $347,866 - $444,193	-990 Reduced 24.9%	2,986 $1.13 Million
Q3 2021 Nov 02, 2021	BUY	$372.64 - $458.3 $147,938 - $181,945	397 Added 11.09%	3,976 $1.64 Million
Q2 2021 Aug 04, 2021	BUY	$294.17 - $371.65 $148,850 - $188,054	506 Added 16.47%	3,579 $1.32 Million
Q1 2021 May 07, 2021	BUY	$249.67 - $299.48 $36,202 - $43,424	145 Added 4.95%	3,073 $891,000
Q4 2020 Jan 26, 2021	BUY	$222.0 - $252.62 $223,554 - $254,388	1,007 Added 52.42%	2,928 $732,000
Q3 2020 Nov 03, 2020	BUY	$175.56 - $226.45 $337,250 - $435,010	1,921 New	1,921 $435,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Redhawk Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Redhawk Wealth Advisors, Inc. with notifications on news.